Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial
奥维瑞巴替尼用于酪氨酸激酶抑制剂(包括帕纳替尼或阿西米尼)治疗失败后的疗效:一项 1b 期随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2024.5157
Jabbour, Elias; Oehler, Vivian G; Koller, Paul B; Jamy, Omer; Lomaia, Elza; Hunter, Anthony M; Uspenskaya, Olga; Samarina, Svetlana; Mukherjee, Sudipto; Cortes, Jorge E; Baer, Maria R; Zherebtsova, Vera; Shuvaev, Vasily; Turkina, Anna; Davydkin, Igor; Guo, Huanshan; Chen, Zi; Fu, Tommy; Jiang, Lixin; Wang, Cunlin; Wang, Hengbang; Yang, Dajun; Zhai, Yifan; Kantarjian, Hagop